HK42394A - Use of lysozyme dimer and/or a ribonuclease dimer for the manufacture of an antiviral or antibiotic drug - Google Patents
Use of lysozyme dimer and/or a ribonuclease dimer for the manufacture of an antiviral or antibiotic drugInfo
- Publication number
- HK42394A HK42394A HK42394A HK42394A HK42394A HK 42394 A HK42394 A HK 42394A HK 42394 A HK42394 A HK 42394A HK 42394 A HK42394 A HK 42394A HK 42394 A HK42394 A HK 42394A
- Authority
- HK
- Hong Kong
- Prior art keywords
- dimer
- antiviral
- ribonuclease
- lysozyme
- manufacture
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17858888A | 1988-05-26 | 1988-05-26 | |
PCT/US1988/001785 WO1989011294A1 (en) | 1988-05-26 | 1988-05-26 | Antiviral or antibacterial compound and method of use |
OA59731A OA09785A (en) | 1988-05-26 | 1990-01-26 | Antiviral or antibacterial compound and method of use |
Publications (1)
Publication Number | Publication Date |
---|---|
HK42394A true HK42394A (en) | 1994-05-13 |
Family
ID=33162813
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK42394A HK42394A (en) | 1988-05-26 | 1994-05-05 | Use of lysozyme dimer and/or a ribonuclease dimer for the manufacture of an antiviral or antibiotic drug |
Country Status (23)
Country | Link |
---|---|
US (3) | US5200182A (fi) |
EP (1) | EP0380484B1 (fi) |
JP (1) | JPH0649659B2 (fi) |
AT (1) | ATE93143T1 (fi) |
AU (1) | AU624331B2 (fi) |
BG (1) | BG60544B1 (fi) |
CA (1) | CA1335425C (fi) |
CS (1) | CS277030B6 (fi) |
DK (1) | DK173078B1 (fi) |
ES (1) | ES2011577A6 (fi) |
FI (1) | FI900412A0 (fi) |
HK (1) | HK42394A (fi) |
HU (1) | HU204710B (fi) |
IL (1) | IL90092A (fi) |
LV (1) | LV10054B (fi) |
MA (1) | MA21560A1 (fi) |
MW (1) | MW390A1 (fi) |
OA (1) | OA09785A (fi) |
PH (1) | PH26284A (fi) |
RU (1) | RU2092183C1 (fi) |
WO (1) | WO1989011294A1 (fi) |
YU (1) | YU109289A (fi) |
ZA (1) | ZA893382B (fi) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1989011294A1 (en) * | 1988-05-26 | 1989-11-30 | Nika Health Care, Inc. | Antiviral or antibacterial compound and method of use |
KR0142172B1 (ko) * | 1990-01-08 | 1998-07-01 | 카를하인츠 리터 | 리보뉴클레아제 이량체를 만드는 개량된 방법 |
US5989880A (en) | 1990-01-08 | 1999-11-23 | Nika Health Products Ltd. | Method of preparing lysozyme dimers |
PL173978B1 (pl) * | 1992-07-13 | 1998-05-29 | Nika Health Products Ltd | Sposób oddziaływania na wydzielanie cytokin w hodowli limfocytów krwi obwodowej |
CH682541A5 (de) * | 1992-06-23 | 1993-10-15 | Urs Viktor Dr Wirth | Biochemische Inaktivierung von RNA-Viren. |
US6183742B1 (en) | 1992-07-13 | 2001-02-06 | Nika Health Products, Limited | Applications of lysozyme dimer |
DZ1964A1 (fr) * | 1995-01-13 | 2002-10-15 | Nika Health Products Ltd | Nouvelle applications d'un dimère de lysozyme. |
GB2304048A (en) * | 1995-08-12 | 1997-03-12 | John William Carson | Medicament containing saliva extract |
US6123937A (en) * | 1997-03-14 | 2000-09-26 | Nika Health Products, Limited | Applications of lysozyme dimer |
US6716813B2 (en) * | 2000-11-28 | 2004-04-06 | House Ear Institute | Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis |
US7338936B2 (en) * | 2000-11-28 | 2008-03-04 | House Ear Institute | Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis |
JP2002187853A (ja) * | 2000-12-21 | 2002-07-05 | Shinei Ferumentekku:Kk | 動物の乳頭除菌剤および菌環境改善方法 |
DE10210285A1 (de) * | 2002-03-08 | 2003-11-13 | Medigene Ag | Reversibles Toxin und seine Verwendung |
WO2005115477A2 (en) * | 2004-04-13 | 2005-12-08 | Quintessence Biosciences, Inc. | Non-natural ribonuclease conjugates as cytotoxic agents |
US20050244402A1 (en) * | 2004-04-30 | 2005-11-03 | Villanueva Julie M | Absorption of pain-causing agents |
US7348301B2 (en) * | 2006-02-16 | 2008-03-25 | Buckman Laboratories International, Inc. | Lysozyme-based method and composition to control the growth of microorganisms in aqueous systems |
US8840882B2 (en) * | 2006-06-23 | 2014-09-23 | Quintessence Biosciences, Inc. | Modified ribonucleases |
WO2008010991A2 (en) | 2006-07-17 | 2008-01-24 | Quintessence Biosciences, Inc. | Methods and compositions for the treatment of cancer |
RU2009136424A (ru) * | 2007-03-02 | 2011-04-10 | СЕНТ СИМЕОН ЭлДиЭй (US) | Композиция и способ лечения папилломавируса и саркоидов лошадей |
WO2009036000A2 (en) * | 2007-09-11 | 2009-03-19 | University Of Maryland, Baltimore | Methods of treating a microbial infection by modulating rnase-l expression and/or activity |
JP2010540681A (ja) * | 2007-10-08 | 2010-12-24 | クインテッセンス バイオサイエンシズ,インコーポレーテッド | リボヌクレアーゼに基づく治療のための組成物及び方法 |
EP2334695B1 (en) | 2008-10-01 | 2015-12-23 | Quintessence Biosciences, Inc. | Therapeutic ribonucleases |
WO2010099182A1 (en) * | 2009-02-25 | 2010-09-02 | Board Of Regents Of The University Of Nebraska | Activated creatinine and precursors as antibacterial agents, compositions and products containing such agents and uses thereof |
NZ600269A (en) | 2009-05-20 | 2014-02-28 | Dec Int Nz Ltd | Delivery device for treatment of mastitis |
PL2457576T3 (pl) | 2010-11-29 | 2021-04-06 | Eurochit Danuta Kruszewska | Szczep Lactobacillus reuteri do stosowania medycznego i weterynaryjnego w profilaktyce oraz w leczeniu zespołu metabolicznego lub infekcji |
RU2548803C2 (ru) * | 2011-11-28 | 2015-04-20 | Общество с ограниченной ответственностью " Фарматренд" | ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ ДЛЯ ЛЕЧЕНИЯ ГЛАЗНЫХ ИНФЕКЦИЙ P. Aeruginosa, СОДЕРЖАЩАЯ РЕКОМБИНАНТНЫЙ ЛИЗОЦИМ |
RU2509801C2 (ru) * | 2012-03-22 | 2014-03-20 | Борис Михайлович Куриненко | СПОСОБ ИСПОЛЬЗОВАНИЯ РИБОНУКЛЕАЗЫ Bacillus intermedius |
EP2674162A1 (en) | 2012-05-29 | 2013-12-18 | Danuta Kruszewska | Nanoproduct comprising lactobacillus reuteri dan080 useful in prophylaxis and medicine, both human and veterinary and medical use of the same |
JP2015520773A (ja) | 2012-05-29 | 2015-07-23 | ダヌタ・クルセフスカDanutaKRUSZEWSKA | ヒトおよび動物における予防および医薬に有用であるラクトバチルス・ロイテリdan80を含むナノ製品ならびにこれらの医薬用途 |
RU2504397C1 (ru) * | 2012-10-25 | 2014-01-20 | Леонид Леонидович Клопотенко | Фармацевтическая композиция, содержащая фермент рибонуклеазу и глицирризиновую кислоту или ее соли: глицирризинат аммония, или дикалия, или тринатрия |
WO2014152678A1 (en) | 2013-03-15 | 2014-09-25 | University Of Massachusetts | Compositions and methods for delivering agents to the central nervous system |
US9573980B2 (en) | 2013-03-15 | 2017-02-21 | Spogen Biotech Inc. | Fusion proteins and methods for stimulating plant growth, protecting plants from pathogens, and immobilizing Bacillus spores on plant roots |
JP5806434B1 (ja) * | 2014-02-21 | 2015-11-10 | 国立大学法人東京海洋大学 | ノロウィルス不活化剤及びその製造方法、ノロウィルス不活化方法、ノロウィルス不活化用リゾチーム類の製造方法、ノロウィルス感染の予防薬又は治療薬、並びにノロウィルス不活化用皮膚外用剤 |
JPWO2016017784A1 (ja) * | 2014-07-31 | 2017-05-18 | キユーピー株式会社 | 含水流動状組成物及びその製造方法、並びに、リゾチーム加工品及び/又はその塩並びにその製造方法 |
BR122023020880A2 (pt) | 2014-09-17 | 2024-01-30 | Spogen Biotech Inc | Método para estimular o crescimento de plantas |
LV15071B (lv) * | 2015-07-14 | 2016-02-20 | Rīgas Stradiņa Universitāte | Kompozīcija subklīniska mastīta ārstēšanai govīm |
RU2634264C1 (ru) * | 2016-09-19 | 2017-10-24 | Александр Ливиевич Ураков | Крем-молочко для лечения опоясывающего лишая |
CN113861760B (zh) | 2016-12-28 | 2023-05-05 | Dic株式会社 | 分散体 |
AR113123A1 (es) | 2017-09-20 | 2020-01-29 | Spogen Biotech Inc | Proteínas de fusión, bacterias recombinantes y fragmentos del exosporio para promover la salud de las plantas |
WO2021021765A1 (en) * | 2019-07-26 | 2021-02-04 | Evolve Biosystems, Inc. | Nutritive compositions with bioactive proteins |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1268M (fr) * | 1961-06-29 | 1962-04-24 | Puiseux | Médicament antimitotique et antiviral. |
FR4020M (fi) * | 1965-01-29 | 1966-03-21 | ||
DE1517751C3 (de) * | 1965-07-08 | 1975-02-27 | Eisai Co., Ltd., Tokio | Verfahren zum Verhindern der Bildung von flockigen Lysozym- und/oder Lysozymsalzniederschlägen in wässrigen Lösungen, die Lysozym und/oder Lysozymsalze enthalten |
DE1545644A1 (de) * | 1965-12-06 | 1969-08-07 | Boehringer Sohn Ingelheim | Verfahren zur Herstellung von neuen quaternaeren Scopolammoniumsalzen |
GB1110504A (en) * | 1966-03-18 | 1968-04-18 | Prodotti Antibiotici Spa | Pharmaceutical compositions |
US4221794A (en) * | 1979-06-21 | 1980-09-09 | Newport Pharmaceuticals International, Inc. | Method of imparting immunomodulating and antiviral activity |
US4510144A (en) * | 1981-08-26 | 1985-04-09 | Newport Pharmaceuticals International | Methods of imparting immunomodulating activity with dihydrothiazolo purine derivatives |
EP0187705A3 (en) * | 1985-01-08 | 1988-05-11 | Norwich Eaton Pharmaceuticals, Inc. | Imidazo(4,5-f)quinolines useful as immunomodulating agents |
US4739046A (en) * | 1985-08-19 | 1988-04-19 | Luzio Nicholas R Di | Soluble phosphorylated glucan |
US4744984A (en) * | 1985-10-08 | 1988-05-17 | Vetrepharm Research, Inc. | Antiviral immunotherapeutic agent and preparation thereof |
WO1989011294A1 (en) * | 1988-05-26 | 1989-11-30 | Nika Health Care, Inc. | Antiviral or antibacterial compound and method of use |
-
1988
- 1988-05-26 WO PCT/US1988/001785 patent/WO1989011294A1/en active IP Right Grant
- 1988-05-26 JP JP63504463A patent/JPH0649659B2/ja not_active Expired - Fee Related
- 1988-05-26 EP EP88905146A patent/EP0380484B1/en not_active Expired - Lifetime
- 1988-05-26 AU AU19408/88A patent/AU624331B2/en not_active Expired
- 1988-05-26 AT AT88905146T patent/ATE93143T1/de not_active IP Right Cessation
- 1988-05-26 US US07/459,738 patent/US5200182A/en not_active Expired - Lifetime
- 1988-05-26 RU SU884743095A patent/RU2092183C1/ru active
- 1988-05-26 HU HU883981A patent/HU204710B/hu unknown
-
1989
- 1989-04-20 CA CA000597341A patent/CA1335425C/en not_active Expired - Fee Related
- 1989-04-27 IL IL9009289A patent/IL90092A/en not_active IP Right Cessation
- 1989-05-08 ZA ZA893382A patent/ZA893382B/xx unknown
- 1989-05-16 ES ES8901637A patent/ES2011577A6/es not_active Expired - Fee Related
- 1989-05-23 PH PH38684A patent/PH26284A/en unknown
- 1989-05-24 MA MA21811A patent/MA21560A1/fr unknown
- 1989-05-26 YU YU01092/89A patent/YU109289A/xx unknown
- 1989-05-26 CS CS893180A patent/CS277030B6/cs not_active IP Right Cessation
-
1990
- 1990-01-22 DK DK199000168A patent/DK173078B1/da not_active IP Right Cessation
- 1990-01-22 MW MW3/90A patent/MW390A1/xx unknown
- 1990-01-25 FI FI900412A patent/FI900412A0/fi not_active IP Right Cessation
- 1990-01-26 OA OA59731A patent/OA09785A/en unknown
- 1990-02-22 BG BG91270A patent/BG60544B1/bg unknown
-
1992
- 1992-04-08 US US07/865,002 patent/US5466449A/en not_active Expired - Lifetime
- 1992-12-28 LV LVP-92-508A patent/LV10054B/en unknown
-
1994
- 1994-05-05 HK HK42394A patent/HK42394A/xx not_active IP Right Cessation
-
1995
- 1995-06-07 US US08/474,663 patent/US6099835A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
MW390A1 (en) | 1990-11-14 |
JPH0649659B2 (ja) | 1994-06-29 |
US5466449A (en) | 1995-11-14 |
ATE93143T1 (de) | 1993-09-15 |
AU1940888A (en) | 1989-12-12 |
CS318089A3 (en) | 1992-05-13 |
EP0380484B1 (en) | 1993-08-18 |
ZA893382B (en) | 1991-01-30 |
AU624331B2 (en) | 1992-06-11 |
US6099835A (en) | 2000-08-08 |
BG60544B1 (en) | 1995-08-28 |
FI900412A0 (fi) | 1990-01-25 |
LV10054B (en) | 1995-02-20 |
HU883981D0 (en) | 1990-12-28 |
CS277030B6 (en) | 1992-11-18 |
BG91270A (bg) | 1993-12-24 |
US5200182A (en) | 1993-04-06 |
DK16890A (da) | 1990-01-22 |
CA1335425C (en) | 1995-05-02 |
IL90092A (en) | 1995-03-30 |
MA21560A1 (fr) | 1989-12-31 |
WO1989011294A1 (en) | 1989-11-30 |
LV10054A (lv) | 1994-05-10 |
OA09785A (en) | 1994-04-15 |
HU204710B (en) | 1992-02-28 |
EP0380484A1 (en) | 1990-08-08 |
JPH03504121A (ja) | 1991-09-12 |
YU109289A (en) | 1991-08-31 |
PH26284A (en) | 1992-04-10 |
DK173078B1 (da) | 1999-12-20 |
HUT54060A (en) | 1991-01-28 |
RU2092183C1 (ru) | 1997-10-10 |
DK16890D0 (da) | 1990-01-22 |
ES2011577A6 (es) | 1990-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK42394A (en) | Use of lysozyme dimer and/or a ribonuclease dimer for the manufacture of an antiviral or antibiotic drug | |
CA2068324A1 (en) | Metal-peptide compositions and methods for stimulating hair growth | |
DE69434963D1 (de) | Selektiv auf die leber wirkende pharmazeutisch aktive substanz | |
CA2212537A1 (en) | Therapeutic inhibitor of vascular smooth muscle cells | |
ES2160643T3 (es) | Composiciones que contienen g-csf y proteina de union al tnf. | |
EP0813409A4 (en) | TREATMENT OF DISEASES CAUSED BY THE CYTOKIN GROWTH FACTOR | |
AU3329293A (en) | Method of imparting antimicrobial activity to an ophthalmic composition | |
AU2840889A (en) | Method of treating haematologic diseases and pharmaceutical compositions to be used therefor | |
CA2079171A1 (en) | Cyclohexapeptidyl propanolamine compounds | |
ES2016464A6 (es) | Procedimiento para preparar derivados de 2', 5' -oligoadenilato. | |
AU5643299A (en) | Humic acid and its use in the treatment of various conditions | |
IL145722A0 (en) | Pharmaceutical composition comprising growth hormone and interferon | |
MY106984A (en) | Antiviral or antibacterial composition and method of use. | |
AU591017B2 (en) | Human monoclonal antibody and drug for prophylaxis and treatment of infectious diseases comprising same as effective ingredient | |
GEP19971029B (en) | Antiviral or antibacterial compound and method of use thereof | |
GR1001006B (el) | Μεθοδος παρασκευης και χρησιμοποιησεως αντιιικων η αντιβακτηριακων συνθεσεων. | |
CA2097878A1 (en) | Therapeutic agent for neutropenia | |
EP0132772A3 (en) | Fr-900216 substance obtainable by cultivating atcc 20577 for use as an active therapeutic substance and pharmaceutical antitumor composition comprising fr-900216 substance | |
MX9307639A (es) | Metodo para tratar infecciones virales con terapia conjuntiva con compuestos similares al aciclovir y un analogo de nucleosido 2'-viril substituido. | |
MY104932A (en) | Immunomodulatory azaspiranes | |
AU2582588A (en) | Pharmaceutical compositions with anti-cancer activity and method for the treatment of cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |